Approaches to pretransplant vaccination. Issue 4 (August 2022)

• Record Type: Journal Article
• Authors: Kates, Olivia S.
• Is Part Of: Current opinion in organ transplantation. Volume 27:Issue 4(2022)
• Page Start: 277
• Page End: 284
• Publication Date: 2022-08
• Subjects: ethics -- pretransplant vaccination -- vaccine hesitancy; Transplantation of organs, tissues, etc -- Periodicals; Immunosuppression -- Periodicals; Transplantation immunology -- Periodicals; 617.954
• DOI: 10.1097/MOT.0000000000000994
• Languages: English
• ISSNs: 1087-2418

Abstract

Abstract : Purpose of review: The aim of this study was to summarize new data and perspectives in pretransplant vaccination, with a particular focus on COVID-19 vaccination and vaccination requirements. Recent findings: Pretransplant vaccination produces superior markers of immunity and is expected to have greater clinical benefit, compared with posttransplant vaccination. As such, efforts are underway to identify and characterize barriers to pretransplant vaccination, with a particular focus on COVID-19 vaccine hesitancy. Unfortunately, vaccine hesitancy is common in transplant patients, often motivated by individual side effect and safety concerns. COVID-19 vaccination requirements have been implemented in some centres, informed by ethical principles, including beneficence, utility and justice. Summary: Barriers to pretransplant vaccination can be understood in three categories: hard stops, including issues of vaccine availability, eligibility, safety and feasibility; soft stops, including issues of convenience, prioritization and care coordination; and volitional stops related to vaccine hesitancy and refusal. All of these barriers present opportunities for improvement based on recent data.